Stay informed with the latest litigation news. Explore now

IP Verse

Ionis Pharmaceuticals patent opposition analysis

Latest patents of Ionis Pharmaceuticals New

Explore the latest patents granted to Ionis Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Aug 31, 2025
Patent NumberGrant DateTitleLegal Status

Get instant update for new patents of Ionis Pharmaceuticals

EP3770258
Jul 17, 2024Modulation Of Ube3A-Ats ExpressionGranted And Under Opposition
EP3400947
Aug 23, 2023Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) PopulationsGranted And Under Opposition
EP2906696
Dec 14, 2022Methods For Modulating C9Orf72 ExpressionPatent Maintained As Amended
EP3461895
Jul 1, 2020Modulation Of Ube3A-Ats ExpressionRevoked
EP2742135
Jun 10, 2020Linkage Modified Gapped Oligomeric Compounds And Uses ThereofPatent Maintained As Amended
EP2399588
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral PolymeraseRevoked
EP3031920
Aug 21, 2019Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) ExpressionRevoked
EP3208347
Aug 14, 2019Selective Reduction Of Allelic VariantsRevoked
EP3321361
Mar 27, 2019Selective Reduction Of Allelic VariantsRevoked
EP2640853
Dec 26, 2018Modulation Of Alpha Synuclein ExpressionRevoked

Latest oppositions filed by Ionis Pharmaceuticals

Explore patent oppositions filed by Ionis Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2752488
Antisense DesignROCHE INNOVATION CENTER COPENHAGENNov 12, 2020

Latest patents of Ionis Pharmaceuticals opposed by its competitors

Explore Ionis Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3770258
Jul 17, 2024Modulation Of Ube3A-Ats Expression3
EP3400947
Aug 23, 2023Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) Populations1
EP2906696
Dec 14, 2022Methods For Modulating C9Orf72 Expression2
EP3461895
Jul 1, 2020Modulation Of Ube3A-Ats Expression1
EP2742135
Jun 10, 2020Linkage Modified Gapped Oligomeric Compounds And Uses Thereof1
EP2399588
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase1
EP3031920
Aug 21, 2019Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression1
EP3208347
Aug 14, 2019Selective Reduction Of Allelic Variants1
EP3321361
Mar 27, 2019Selective Reduction Of Allelic Variants1
EP2640853
Dec 26, 2018Modulation Of Alpha Synuclein Expression1

Top competitors of Ionis Pharmaceuticals

Top competitors of Ionis Pharmaceuticals based on patent oppositions.